APA (7th ed.) Citation

Minomo, A., Ishima, Y., Chuang, V., Suwa, Y., Kragh-Hansen, U., Narisoko, T., . . . Otagiri, M. (2013). Albumin domain II mutant with high bilirubin binding affinity has a great potential as serum bilirubin excretion enhancer for hyperbilirubinemia treatment. Elsevier BV.

Chicago Style (17th ed.) Citation

Minomo, Ai, Yu Ishima, Victor Chuang, Yoshiaki Suwa, Ulrich Kragh-Hansen, Toru Narisoko, Hiroshi Morioka, Toru Maruyama, and Masaki Otagiri. Albumin Domain II Mutant with High Bilirubin Binding Affinity Has a Great Potential as Serum Bilirubin Excretion Enhancer for Hyperbilirubinemia Treatment. Elsevier BV, 2013.

MLA (9th ed.) Citation

Minomo, Ai, et al. Albumin Domain II Mutant with High Bilirubin Binding Affinity Has a Great Potential as Serum Bilirubin Excretion Enhancer for Hyperbilirubinemia Treatment. Elsevier BV, 2013.